Pfizer Inc.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
Rates of Inflammatory Bowel Disease (IBD) are increasing across the globe, and there are many complexities around management and patient care. Meeting this growing need requires developing a workforce that is specifically trained in the care of IBD patients. It is not entirely practical to expect that the traditional three-year Gastroenterology (GI) fellowship program can adequately address more than the traditional scope of GI care. Therefore, we seek to provide funding through this RFP to support programs that will encourage collaboration between the existing US IBD Fellowship sites, with a goal to develop training program(s) that aim to achieve consistency across these Fellowship program sites.
The intent of this RFP is to encourage academic organizations or leading associations to design structured programs that harmonize IBD Fellow Training in the US. The intended target audience includes early career IBD practitioners and those enrolled in or soon-to-be enrolled in IBD-specific Fellowships, as well as the Fellowship Directors.
Grant Application due date: April 12, 2021